Vmbook Online ordering

Icons

**Company Name:** ICON plc

**Stock Symbol:** ICON (NASDAQ)

**Industry:** Contract Research Organization (CRO)

**Headquarters:** Dublin, Ireland

**Business Overview:**

ICON is a global CRO that provides a range of clinical research services to pharmaceutical, biotechnology, and medical device companies. Its services include clinical trial design, execution, data management, and statistical analysis.

**Suitcase Business:**

ICON's "Suitcase" business refers to its decentralized clinical trial model, which leverages technology and remote patient monitoring to conduct trials in patients' homes or local communities. This model aims to improve patient convenience, reduce costs, and accelerate clinical development timelines.

**Earnings and Growth:**

**Revenue:**

* 2022: $5.1 billion

* 2021: $4.3 billion

* 2020: $3.7 billion

**Net Income:**

* 2022: $452.2 million

* 2021: $363.5 million

* 2020: $266.4 million

**Diluted Earnings Per Share:**

* 2022: $2.64

* 2021: $2.13

* 2020: $1.57

**Growth:**

ICON has experienced consistent growth in recent years, driven by increasing demand for clinical research services and the adoption of its Suitcase model.

**Key Metrics:**

* Number of active clinical trials: 2,500+

* Number of countries with operations: 150+

* Number of employees: 18,000+

**Stock Performance:**

ICON's stock price has performed well over the past year, outperforming the broader market.

**Analyst Coverage:**

ICON is covered by several major investment banks, including Morgan Stanley, Goldman Sachs, and Credit Suisse. Analysts generally have a positive outlook on the company due to its strong growth prospects and innovative clinical trial model.